Milton H. Werner
2023
In 2023, Milton H. Werner earned a total compensation of $811.4K as President and Chief Executive Officer at Inhibikase Therapeutics, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $170,850 |
|---|---|
| Option Awards | $113,472 |
| Salary | $510,000 |
| Other | $17,107 |
| Total | $811,429 |
Werner received $510K in salary, accounting for 63% of the total pay in 2023.
Werner also received $170.9K in non-equity incentive plan, $113.5K in option awards and $17.1K in other compensation.
Rankings
In 2023, Milton H. Werner's compensation ranked 1,440th out of 2,978 executives tracked by ExecPay. In other words, Werner earned more than 51.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,440 out of 2,978 | 52nd |
Division Manufacturing | 852 out of 1,637 | 48th |
Major group Chemicals And Allied Products | 555 out of 906 | 39th |
Industry group Drugs | 541 out of 869 | 38th |
Industry Biological Products, Except Diagnostic Substances | 150 out of 211 | 29th |
Source: SEC filing on November 18, 2024.
Werner's colleagues
We found one more compensation record of an executive who worked with Milton H. Werner at Inhibikase Therapeutics in 2023.
2023
Joseph Frattaroli
Inhibikase Therapeutics